EUVIMED · CrossrefJournal
Transfuze a hematologie dnes
ISSN 1213-5763 · Care Comm
Latest articles
Thrombotic microangiopathy in the maternity ward from the anaesthesiologist‘s perspective – a case study
Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy
Implementation of the SoHO Regulation and the Management of the Plasma Collection System in the Czech Republic – discussion and position of an interdisciplinary panel
The change of prognosis of 1,492 nonselected patients with multiple myeloma during 60 years in the Middle and partially in the North Moravia region
Procedure for the administration of irradiated blood components Recommendations of the Society for Transfusion Medicine of the Czech Medical Association JEP
Development of the epidemiological situation of Hodgkin’s lymphoma in the Czech Republic in the period 2000–2019
Resistance to BTK inhibitors in chronic lymphocytic leukaemia – from the C481S mutation to non-genetic mechanisms of tumour adaptation
Recommendation of the Society for Transfusion Medicine No. 20 Cold red blood cell antibodies testing before cardiothoracic surgery on cardiopulmonary bypass
Antifungal prophylaxis in patients with acute myeloid leukaemia treated with venetoclax and azacitidine
Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients
What can be expected from venetoclax + azacitidine (VEN+AZA) in acute myeloid leukaemia (AML) – results from VIALE-A and post-hoc analyses
Acute myeloid leukaemia – how the approach to diagnosis, risk stratification, and treatment options has changed
Concurrent occurrence of BCR:: ABL1-positive chronic myeloid leukaemia and Philadelphia-negative myeloproliferative neoplasm
Principles of Rational Haemotherapy Interdisciplinary Consensus Statement
Treatment of multiple myeloma with manifestations of light chain deposition disease; complete remission with minimal residual disease negativity following treatment with daratumumab, dexamethasone, and lenalidomide – a case report and a review of the literature
Changes in the immune system of untreated patients with chronic lymphocytic leukaemia – part 1: adaptive immunity
Mucormycosis – review of literature and case report
A peripherally inserted central catheter is a safe means of ensuring long-term central venous access in patients with acute leukaemia – a single centre experience
Transfusion related acute lung injury (TRALI) prevention – selection of donors for producing plasma designated for clinical use
Obinutuzumab in the treatment of a patient with Waldenström macroglobulinemia and rituximab intolerance – a case report
Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication
Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors
What is the optimal dose of tyrosine kinase inhibitors in chronic myeloid leukaemia?
Von Willebrand disease – comparison of two methods of vWF multimer analysis
Blood cell analysers – signifi cance of a dimorphic red blood cell population
Muscle pain as a rare autoimmune symptom of monoclonal IgM gammopathy – case report and overview of autoimmune manifestations associated with monoclonal immunoglobulins
"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"
Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the dia gnosis and treatment of patients with haemophilia, 3rd edition, year 2021
Recommendations for chronic lymphocytic leukaemia dia gnosis and therapy 2021
How do anti-SARS-CoV-2 IgG and IgM predict the titre of virus-neutralizing antibodies in donors of convalescent plasma against COVID-19 disease?
EUVIMED